Regeneron and Sanofi Look for Billions From COPD Drug

[ad_1] The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease. [ad_2] Source link

Regeneron Borrows From Big Pharma Playbook to Keep Roche, Shorts at Bay

[ad_1] Eylea, the company’s top-selling blockbuster, isn’t going away soon. [ad_2] Source link

As the U.S. Gets Older, Some ETFs Bet on Aging in Place

[ad_1] A number of thematic funds are focused on companies that help seniors who want to stay in their homes as long as possible. [ad_2] Source link